05:43 PM EDT, 08/22/2024 (MT Newswires) -- NKGen Biotech ( NKGN ) said Thursday it has been notified by Nasdaq that it is not in compliance with the exchange's listing rule on the timely filing of the Form 10-Q report for the quarter ended June 30.

The company said it failed to file the report on time because of a recent change in its accounting firm and valuation firm.

NKGen said it has until Oct. 21 to submit a plan to regain compliance.